• @[email protected]
    link
    fedilink
    168 months ago

    Dostarlimab is a drug with laboratory-produced molecules that act as substitute antibodies in the human body. All 18 rectal cancer patients were given the same drug and as a result of the treatment, cancer was completely obliterated in every patient - undetectable by physical exam; endoscopy; positron emission tomography or PET scans or MRI scans.

    • @[email protected]
      link
      fedilink
      98 months ago

      Apparently Dostarlimab is very expensive ($11,000 per dose), but hopefully as it gets more streamlined it becomes cheaper.